Logan Reed
Yellow fever is a dangerous disease caused by a virus transmitted by infected mosquitoes. The yellow fever vaccine is a live, weakened form of the virus, which is injected to prevent infection. The vaccine has been in use since 1938 and is recommended for people over the age of 9 months who are travelling to or living in areas where yellow fever is common. While the vaccine is considered safe, with mild side effects, there is a small risk of severe, life-threatening reactions, including allergic reactions, neurological disease, and multi-organ failure. Therefore, it is important to carefully consider the risks and benefits before receiving the vaccine.
| Characteristics | Values |
|---|---|
| Type of Virus | Live, weakened form of the virus |
| Age Recommendation | 9 months or older |
| Effectiveness | Long-lasting protection, booster dose not needed |
| Side Effects | Headaches, muscle aches, low-grade fevers, allergic reactions, swelling of the brain, spinal cord, Guillain-Barré syndrome |
| Risk Factors | Older age, egg allergy, compromised immune system, very young children |
| Areas Recommended | Africa, South America |
| Administration | Injection under the skin |
| Precautions | Avoid during pregnancy and breastfeeding, not for infants under 9 months |
| Certificate | International certificate (yellow card) valid for 10 years |
Explore related products
![International Certificate of Vaccination with Vinyl Document Holder - World Health Organization Bilingual Version [cards] World Health Organization [Jan 01, 2007]](https://m.media-amazon.com/images/I/61SHjBP1VYL._AC_UY218_.jpg)
What You'll Learn
- The yellow fever vaccine is a live, weakened form of the virus
- It is recommended for people over 9 months old travelling to at-risk areas
- It can be administered at the same time as other live vaccines
- There is a small risk of severe adverse reactions, including YEL-AVD and YEL-AND
- The vaccine is not recommended during pregnancy or breastfeeding
The yellow fever vaccine is a live, weakened form of the virus
The yellow fever vaccine has been in use since 1938, with the first modern attempts to develop it beginning in 1912. The vaccine is considered safe, with over 500 million doses administered and very few documented cases of associated illness. Typically, a single dose is sufficient to confer immunity, and a booster dose is not usually needed. However, travellers going to areas with ongoing outbreaks may consider a booster if it has been ten years or more since their last vaccination. Additionally, certain countries may require a booster for entry.
The vaccine is generally well-tolerated, with mild side effects including headaches, muscle aches, and low-grade fevers. These side effects typically last for a few days and resolve without intervention. However, in rare cases, more severe reactions can occur, such as allergic reactions, swelling of the brain or spinal cord, and Guillain-Barré syndrome. These severe reactions are more common in individuals over 60 years of age. Therefore, it is recommended that older adults receive the vaccine only if they are fit and well, fully understand the risks, and have a genuine risk of contracting yellow fever at their destination.
The yellow fever vaccine can usually be safely administered to individuals with HIV infection, provided their CD4 counts are above 200 and their condition is stable. However, it is typically avoided during pregnancy and breastfeeding due to potential risks. Additionally, those with a known egg allergy should exercise caution, as the majority of adverse reactions to the vaccine are a result of allergic responses to the eggs in which the vaccine is grown.
While the yellow fever vaccine is effective in preventing the disease, it is not without its limitations. In very rare cases, individuals may develop a severe form of yellow fever-like disease known as Yellow Fever Vaccine-Associated Acute Viscerotropic Disease (YEL-AVD), which has a high mortality rate. Another rare complication is Yellow Fever Vaccine-Associated Acute Neurotropic Disease (YEL-AND), which affects the brain and nervous system. These rare but serious adverse events highlight the importance of careful consideration of contraindications and precautions before administering the vaccine.
The Mystery of West Nile Virus Vaccines
You may want to see also
Explore related products
It is recommended for people over 9 months old travelling to at-risk areas
The yellow fever vaccine is a live, weakened form of the virus. It is recommended for anyone over the age of 9 months who is travelling to or living in areas where yellow fever is present. This includes countries in Africa and South America. The vaccine is not suitable for infants under 9 months old, and it is generally recommended that it is avoided during pregnancy and breastfeeding. Those with a known egg allergy should also take precautions, as the vaccine is grown in eggs, and this is a common source of allergic reactions.
The vaccine is administered via injection and is designed to prevent infection from the yellow fever virus, which is transmitted by infected mosquitoes. The World Health Organization (WHO) recommends the vaccine for children over 9 months old in areas where yellow fever is common. The vaccine is also recommended for lab personnel working with the virus and travellers to at-risk areas.
Yellow fever is a dangerous disease that causes significant morbidity and mortality. It typically presents with flu-like symptoms, followed by a period of remission, and then approximately 1 in 7 infected people will enter a period of intoxication, with symptoms including jaundice, hemorrhages, high fever, dark urine, shock, and organ failure. There are no specific treatments, so prevention through vaccination is critical.
The yellow fever vaccine is generally safe, with over 500 million doses administered and very few documented cases of associated illness. However, there is a small risk of severe adverse reactions, including allergic reactions, YEL-AND (a nervous system disorder), and YEL-AVD, a severe disease resembling yellow fever caused by virulent strains of the virus. These severe reactions are rare, but individuals over 60 are at a higher risk of experiencing them.
To summarise, the yellow fever vaccine is recommended for people over 9 months old travelling to at-risk areas, as it offers important protection against a dangerous disease. While generally safe, there are risks of adverse reactions, particularly for those over 60, so it is important to discuss the vaccine with a healthcare provider before travelling to ensure it is appropriate for your specific circumstances.
Blue Cross Blue Shield Illinois: Understanding Your Vaccine Coverage
You may want to see also
Explore related products
![Hell of the Living Dead ( Virus ) [ Blu-Ray, Reg.A/B/C Import - Spain ]](https://m.media-amazon.com/images/I/41ORNMRLdLL._AC_UY218_.jpg)
It can be administered at the same time as other live vaccines
The yellow fever vaccine is a live, weakened form of the virus. It is recommended for people who are 9 months old or older and are travelling to or living in areas at risk for yellow fever in Africa and South America. The vaccine protects against yellow fever and helps to prevent its spread. It is important to get vaccinated at least 10 days before travelling to an endemic area to ensure full immunity.
While the yellow fever vaccine is generally safe, with over 500 million doses administered and very few cases of vaccine-associated illness, there is a small risk of severe adverse reactions. These include allergic reactions, yellow fever vaccine-associated acute viscerotropic disease (YEL-AVD), and yellow fever vaccine-associated acute neurotropic disease (YEL-AND). The risk of YEL-AVD is estimated to be 1.2 cases per 100,000 doses for individuals over 60 years of age and 0.3 cases per 100,000 doses for those under 60.
Due to the risk of adverse reactions, it is recommended that only those at risk of exposure to yellow fever or requiring proof of vaccination for country entry receive the vaccine. Healthcare providers should carefully consider the contraindications and precautions before administering the vaccine. Additionally, the yellow fever vaccine should typically be avoided during pregnancy and while breastfeeding.
Despite the risks, the benefits of the yellow fever vaccine are significant. It reduces the risk of contracting yellow fever and provides long-lasting protection, with most people requiring only a single dose. The vaccine is also compatible with the concurrent administration of other live vaccines, such as oral cholera and typhoid vaccines. However, if simultaneous administration is not possible, it is recommended to wait at least 30 days between vaccinations to avoid impairing the immune response.
In summary, the yellow fever vaccine is a live, weakened virus that can be safely administered to most individuals at risk of exposure to yellow fever. It can be given at the same time as other live vaccines, but appropriate precautions and timing should be considered to minimise the risk of adverse reactions.
Pneumonia Vaccine for Seniors: Free or Fee?
You may want to see also
Explore related products
$11.93 $21.99
There is a small risk of severe adverse reactions, including YEL-AVD and YEL-AND
The yellow fever vaccine is a live, weakened form of the virus. It is recommended for people who are 9 months old or older and are travelling to or living in areas at risk of yellow fever in Africa and South America. The vaccine is usually administered via injection. While it is considered safe, with very few documented cases of vaccine-associated illness, there is a small risk of severe adverse reactions, including YEL-AVD and YEL-AND.
YEL-AVD, or yellow fever vaccine-associated viscerotropic disease, produces a condition similar to yellow fever, with multi-organ failure and death in approximately 48% of cases. The risk factors for YEL-AVD are not known, but it may be genetic. The risk of YEL-AVD occurring is estimated to be 1.2 cases per 100,000 doses of vaccine administered for those over 60 years of age, and 0.3 cases per 100,000 doses for those under 60.
YEL-AND, or yellow fever vaccine-associated acute neurotropic disease, is a condition affecting the brain and nervous system. It is a rare but serious complication that can occur after receiving the yellow fever vaccine, particularly in individuals with compromised immune systems and very young children.
To mitigate the risk of severe adverse reactions, clinicians should only vaccinate persons at risk for exposure to the yellow fever virus or those who require proof of vaccination for country entry. Healthcare providers should carefully observe the contraindications and consider the precautions about vaccination before administering the vaccine.
While the yellow fever vaccine is generally safe and effective, there is a small risk of severe adverse reactions, including YEL-AVD and YEL-AND. It is important for individuals to weigh the benefits and risks of the vaccine and consult with a healthcare provider before getting vaccinated.
Hepatitis A & B: Vaccination Options and Availability
You may want to see also
Explore related products
The vaccine is not recommended during pregnancy or breastfeeding
The yellow fever vaccine is a live, weakened form of the virus. It is recommended for people who are 9 months old or older and who are travelling to or living in areas where there is a risk of contracting the yellow fever virus, such as in Africa and South America.
Pregnant and breastfeeding women are typically advised to avoid the yellow fever vaccine. A healthcare practitioner will assess the risks and benefits of vaccination in these circumstances and may recommend alternative measures of protection, such as avoiding mosquito bites. This is because there is a small risk of severe adverse reactions to the vaccine, including allergic reactions, neurological conditions, and multi-organ failure, which could potentially affect both mother and child.
Pregnant women should be especially cautious as the vaccine may increase the risk of miscarriage or birth defects. While there is limited data on the impact of the vaccine during pregnancy, the potential benefits of vaccination may outweigh the risks in certain situations. For example, if a pregnant woman must travel to an area with a high risk of yellow fever transmission, a healthcare practitioner may advise vaccination after a careful evaluation of her medical history and travel plans.
Breastfeeding women, on the other hand, may be advised to temporarily discontinue breastfeeding for a period of time after receiving the vaccine to minimise any potential risk of adverse effects on the infant. This is because the vaccine virus can be transmitted through breast milk in rare cases. However, the benefits of breastfeeding are also important to consider, and alternatives such as formula feeding may be recommended temporarily.
In conclusion, while the yellow fever vaccine is generally safe and effective for most individuals, it is not recommended during pregnancy or breastfeeding due to potential risks. Healthcare practitioners will assess each case individually and provide personalised advice to ensure the safety and well-being of both mother and child.
Free Vaccines: What Employers Must Offer to Staff
You may want to see also
Frequently asked questions
The yellow fever vaccine is an injection that prevents infection from the yellow fever virus. It is recommended for people who are 9 months old or older and are travelling to or living in areas at risk for yellow fever.
Yes, the yellow fever vaccine is a live, weakened form of the virus. It is known as a live-attenuated vaccine.
The vaccine helps your immune system learn how to fight off a future infection. It is administered by injection under the skin.
Mild side effects such as headaches, muscle aches, and low-grade fevers are common. In rare cases, people may develop severe or life-threatening reactions, including allergic reactions, neurological diseases, and viscerotropic diseases.
